You have 9 free searches left this month | to do more

Fludarabine

Fludarabine is a drug used to treat Leukemia, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and other conditions. Fludarabine is being actively studied in 321 studies and prior, has been studied in 190.

Top SponsorsTop SitesTop Investigators
M.D. Anderson Cancer CenterNational Institutes of Health Clinical Center, 9000 Rockville PikeSteven Rosenberg, M.D.
National Cancer Institute (NCI)University of Texas MD Anderson Cancer CenterRichard Burt, MD
Baylor College of MedicineMemorial Sloan Kettering Cancer CenterRobert Krance
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Completed
  • Hematologic Malignancies
  • +7 more
  • Fludarabine
  • San Francisco, California
    University of California, San Francisco
2021-09-27
Sep 27, 2021
N
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-12-02
Dec 2, 2021
U
Recruiting
  • Acute Myeloid Leukemia, Adult
  • +2 more
  • La Jolla, California
    UCSD Moores Cancer Center
2021-03-30
Mar 30, 2021
N
Completed
  • Aplastic Anemia
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-06-07
Jun 7, 2021
S
Recruiting
  • Leukemia, Acute Lymphoblastic
  • +5 more
  • Fludarabine
  • +5 more
  • Saint Petersburg, Russian Federation
    RM Gorbacheva Research Institute
2021-06-21
Jun 21, 2021
M
Recruiting
  • Hematological Malignancy
  • +3 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
2021-05-25
May 25, 2021
M
Completed
  • Disorder Related to Bone Marrow Transplantation
  • +2 more
  • Fludarabine
  • +6 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-11-18
Nov 18, 2021
N
Active, not recruiting
  • Adult T-Cell Leukemia (ATL)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-02-18
Feb 18, 2021
U
Active, not recruiting
  • Pleural Mesothelioma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
2021-04-11
Apr 11, 2021
M
Completed
  • Stem Cell Transplantation
  • Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
2020-09-22
Sep 22, 2020
S
Recruiting
  • Myelogenous Leukemia, Acute
  • Ramat Gan, Israel
    Chaim Sheba Medical Center
2021-09-21
Sep 21, 2021
C
Recruiting
  • Sickle Cell Disease
  • +2 more
  • Fludarabine
  • Hematopoietic Stem Cell Transplant (HSCT)
  • Cleveland, Ohio
    University Hospitals Seidman Cancer Center, Case Comprehensive C
2021-07-06
Jul 6, 2021
N
Active, not recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Fludarabine
  • Total Marrow Irradiation (TMI)
  • Indianapolis, Indiana
    Indiana University Melvin & Bren Simon Cancer Center
2021-03-16
Mar 16, 2021
U
Active, not recruiting
  • Adult Lymphoblastic Lymphoma
  • Fludarabine
  • Total Body Irradiation
  • Birmingham, Alabama
    UAB Bone Marrow Transplantation and Cellular Therapy Program
2021-06-24
Jun 24, 2021
M
Recruiting
  • Hematologic Malignancies
  • Busulfan 3.2 mg/kg/day
  • +5 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-11-10
Nov 10, 2021
C
Recruiting
  • Leukemia
  • Cleveland, Ohio
    University Hospitals Seidman Cancer Center, Case Comprehensive C
2021-06-21
Jun 21, 2021
W
Active, not recruiting
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • Morgantown, West Virginia
    West Virginia University Hospitals Mary Babb Randolph Cancer Cen
2021-04-06
Apr 6, 2021
M
Completed
  • Myelodysplastic Syndrome
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-01-12
Jan 12, 2021
M
Completed
  • Lymphoma
  • Fludarabine
  • +4 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-02-15
Feb 15, 2021
M
Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-12
Nov 12, 2021
M
Active, not recruiting
  • B-Lymphoid Malignancies
  • +3 more
  • Fludarabine
  • +4 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-11-18
Nov 18, 2021
D
Active, not recruiting
  • Leukemia, Lymphoid
  • +6 more
  • Fludarabine
  • +3 more
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
2021-01-29
Jan 29, 2021
H
Active, not recruiting
  • Sickle Cell Disease
  • Hackensack, New Jersey
    Hackensack University Medical Center
2021-02-03
Feb 3, 2021
I
Active, not recruiting
  • Cancer
  • Solid Tumor
  • Fludarabine
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-08-18
Aug 18, 2021